首页 > 最新文献

Vox Sanguinis最新文献

英文 中文
The safety of pathogen-reduced platelet transfusions in critically ill term and preterm neonates. 为危重的足月和早产新生儿输注减少病原体的血小板的安全性。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-30 DOI: 10.1111/vox.13762
Alexia D'hont, Ginette M Ecury-Goossen, Ruben J Overduin, Meindert E Manshande, Ashley J Duits

Background and objectives: Platelet transfusions carry an important risk of infection transmission. The Mirasol Pathogen Reduction Technology system for platelets uses riboflavin and UV light to introduce irreparable lesions into nucleic acids, thereby inhibiting pathogen replication and inactivating white blood cells. The objective of this study is to evaluate the safety of pathogen-reduced platelet transfusions (PRPTs) in critically ill infants in a neonatal intensive care unit (NICU) in the Caribbean.

Materials and methods: We conducted a descriptive retrospective study of the use of Mirasol PRPTs in patients admitted to the NICU of the general hospital in Curaçao from February 2016 to April 2023.

Results: A total of 208 PRPTs were administered to 46 patients (median [range] transfusions per patient: 3 [1-24]). Three patients were born term, and 43 were born preterm (median [range] gestational age: 27 4/7 weeks [24 6/7-36 6/7]). PRPTs were well-tolerated and no complications occurred, especially no signs of haemolysis nor any signs of new infection within 24 h after transfusion. Twenty-one of 46 patients (46%) died during their admittance. None of the deaths were deemed related to PRPT.

Conclusion: Mirasol PRPT appears to be safe for use in critically ill neonates, including extremely preterm neonates.

背景和目的:血小板输注具有重要的感染传播风险。用于血小板的 Mirasol 减少病原体技术系统使用核黄素和紫外线将不可修复的病变引入核酸,从而抑制病原体复制并使白细胞失活。本研究旨在评估加勒比海地区新生儿重症监护室(NICU)重症婴儿输注病原体还原血小板(PRPT)的安全性:我们对2016年2月至2023年4月期间库拉索岛综合医院新生儿重症监护室收治的患者使用Mirasol PRPTs的情况进行了描述性回顾研究:46名患者共使用了208次PRPTs(每名患者输血量的中位数[范围]:3 [1-24])。3名患者为足月儿,43名患者为早产儿(胎龄中位数[范围]:27 4/7 周[24 6/7-36 6/7])。PRPT 耐受良好,未出现并发症,尤其是输血后 24 小时内未出现溶血迹象或新感染迹象。46 名患者中有 21 人(46%)在住院期间死亡。结论:Mirasol PRPT 的效果似乎不错:Mirasol PRPT 用于重症新生儿(包括早产儿)似乎是安全的。
{"title":"The safety of pathogen-reduced platelet transfusions in critically ill term and preterm neonates.","authors":"Alexia D'hont, Ginette M Ecury-Goossen, Ruben J Overduin, Meindert E Manshande, Ashley J Duits","doi":"10.1111/vox.13762","DOIUrl":"10.1111/vox.13762","url":null,"abstract":"<p><strong>Background and objectives: </strong>Platelet transfusions carry an important risk of infection transmission. The Mirasol Pathogen Reduction Technology system for platelets uses riboflavin and UV light to introduce irreparable lesions into nucleic acids, thereby inhibiting pathogen replication and inactivating white blood cells. The objective of this study is to evaluate the safety of pathogen-reduced platelet transfusions (PRPTs) in critically ill infants in a neonatal intensive care unit (NICU) in the Caribbean.</p><p><strong>Materials and methods: </strong>We conducted a descriptive retrospective study of the use of Mirasol PRPTs in patients admitted to the NICU of the general hospital in Curaçao from February 2016 to April 2023.</p><p><strong>Results: </strong>A total of 208 PRPTs were administered to 46 patients (median [range] transfusions per patient: 3 [1-24]). Three patients were born term, and 43 were born preterm (median [range] gestational age: 27 4/7 weeks [24 6/7-36 6/7]). PRPTs were well-tolerated and no complications occurred, especially no signs of haemolysis nor any signs of new infection within 24 h after transfusion. Twenty-one of 46 patients (46%) died during their admittance. None of the deaths were deemed related to PRPT.</p><p><strong>Conclusion: </strong>Mirasol PRPT appears to be safe for use in critically ill neonates, including extremely preterm neonates.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"76-79"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142547823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis of efficacy and safety of pathogen-reduced platelet components: Request for clarification. 病原体还原血小板成分的有效性和安全性的 Meta 分析:请求澄清。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-27 DOI: 10.1111/vox.13754
Nancy M Heddle, Jean Louis Kerkhoffs, Paolo Rebulla
{"title":"Meta-analysis of efficacy and safety of pathogen-reduced platelet components: Request for clarification.","authors":"Nancy M Heddle, Jean Louis Kerkhoffs, Paolo Rebulla","doi":"10.1111/vox.13754","DOIUrl":"10.1111/vox.13754","url":null,"abstract":"","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"104-105"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimated Plasmodium 18S ribosomal RNA prevalence in asymptomatic blood donors from three African countries. 非洲三国无症状献血者中疟原虫 18S 核糖体 RNA 的估计流行率。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-30 DOI: 10.1111/vox.13756
Laura Tonnetti, Jamel A Groves, Deanna Self, Manisha C Yadav, Claude Tayou Tagny, Olivat A Rakoto Alson, Kristin Livezey, Jeffery M Linnen, Susan L Stramer

Background and objectives: The World Health Organization (WHO) African Region accounts for 94% of malaria cases globally, with variability recognized within endemic regions. To determine the detection rate of Plasmodium RNA in blood donors resident in malaria-endemic areas, samples from three African countries were tested using a Plasmodium nucleic acid test.

Materials and methods: Whole blood (WB) samples collected from routine donors in Cameroon, Madagascar and Mali were shipped frozen to the United States. Samples were tested individually from WB lysates with the Procleix Plasmodium assay (transcription-mediated amplification [TMA]). Reactive samples were considered either repeat reactive or initial reactive only, depending on TMA-retest results. When available, matching plasma samples were tested for Plasmodium antibodies by enzyme immunoassay (EIA).

Results: Plasmodium repeat reactivity ranged from 41% (91/223 tested) in Cameroon to 12% (26/216) in Mali and 1% (3/249) in Madagascar. Initially reactive samples, where reactivity did not repeat, were identified from Cameroon (5/223; 2%) and Mali (2/216; 1%). The matched-plasma subgroup had EIA reactivity ranging from 86% (113/131 tested) in Cameroon to 59% (10/17) in Mali and 27% (68/248) in Madagascar.

Conclusion: Plasmodium ribosomal RNA (rRNA) detection and antibody rates varied greatly in the three countries studied. Detection of Plasmodium rRNA can provide an additional tool to address malaria risk in blood donors.

背景和目标:世界卫生组织(WHO)非洲地区的疟疾病例占全球疟疾病例的94%,但在疟疾流行地区内部存在差异。为了确定疟疾流行地区献血者体内疟原虫 RNA 的检出率,使用疟原虫核酸检测法对来自三个非洲国家的样本进行了检测:从喀麦隆、马达加斯加和马里的常规献血者处采集的全血(WB)样本被冷冻运往美国。用 Procleix 疟原虫检测法(转录介导扩增法 [TMA])对全血(WB)裂解液中的样本进行单独检测。根据 TMA 重测结果,反应样本被视为重复反应样本或仅初始反应样本。如果有匹配的血浆样本,则用酶免疫分析法(EIA)检测疟原虫抗体:疟原虫重复反应率从喀麦隆的 41%(91/223)到马里的 12%(26/216)和马达加斯加的 1%(3/249)不等。在喀麦隆(5/223;2%)和马里(2/216;1%)发现了初次反应样本,这些样本的反应性没有重复。匹配血浆亚组的 EIA 反应性从喀麦隆的 86%(113/131 例检测)到马里的 59%(10/17 例)和马达加斯加的 27%(68/248 例)不等:结论:在所研究的三个国家中,疟原虫核糖体 RNA(rRNA)的检测率和抗体率差异很大。疟原虫核糖体 RNA 的检测可为解决献血者的疟疾风险提供额外的工具。
{"title":"Estimated Plasmodium 18S ribosomal RNA prevalence in asymptomatic blood donors from three African countries.","authors":"Laura Tonnetti, Jamel A Groves, Deanna Self, Manisha C Yadav, Claude Tayou Tagny, Olivat A Rakoto Alson, Kristin Livezey, Jeffery M Linnen, Susan L Stramer","doi":"10.1111/vox.13756","DOIUrl":"10.1111/vox.13756","url":null,"abstract":"<p><strong>Background and objectives: </strong>The World Health Organization (WHO) African Region accounts for 94% of malaria cases globally, with variability recognized within endemic regions. To determine the detection rate of Plasmodium RNA in blood donors resident in malaria-endemic areas, samples from three African countries were tested using a Plasmodium nucleic acid test.</p><p><strong>Materials and methods: </strong>Whole blood (WB) samples collected from routine donors in Cameroon, Madagascar and Mali were shipped frozen to the United States. Samples were tested individually from WB lysates with the Procleix Plasmodium assay (transcription-mediated amplification [TMA]). Reactive samples were considered either repeat reactive or initial reactive only, depending on TMA-retest results. When available, matching plasma samples were tested for Plasmodium antibodies by enzyme immunoassay (EIA).</p><p><strong>Results: </strong>Plasmodium repeat reactivity ranged from 41% (91/223 tested) in Cameroon to 12% (26/216) in Mali and 1% (3/249) in Madagascar. Initially reactive samples, where reactivity did not repeat, were identified from Cameroon (5/223; 2%) and Mali (2/216; 1%). The matched-plasma subgroup had EIA reactivity ranging from 86% (113/131 tested) in Cameroon to 59% (10/17) in Mali and 27% (68/248) in Madagascar.</p><p><strong>Conclusion: </strong>Plasmodium ribosomal RNA (rRNA) detection and antibody rates varied greatly in the three countries studied. Detection of Plasmodium rRNA can provide an additional tool to address malaria risk in blood donors.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"71-75"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142547820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Forum on Global Patient Blood Management: Summary. 全球患者血液管理国际论坛:摘要。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-13 DOI: 10.1111/vox.13760
Yashaswi Dhiman, Katerina Pavenski, Gopal Patidar, Teguh Triyono, Tomohiko Sato, Arwa Z Al-Riyami, Nasser Al-Kemyani, Marc Maegele, Vijay Kumawat, Parmatma Prasad Tripathi, Basanta Khatiwada, Marc Bienz, Alanna Howell, Philip J Crispin, Naomi Rahimi-Levene, Maha A Badawi, Salwa Hindawi, María Antonieta Núñez, Edgardo Saa, Riin Kullaste, Richard R Gammon, Marni Dargis, Samclide Mbikayi Mutindu, Alphonse Mosolo, Amalia Bravo Lindoro, Lise Estcourt, Nancy Dunbar
{"title":"International Forum on Global Patient Blood Management: Summary.","authors":"Yashaswi Dhiman, Katerina Pavenski, Gopal Patidar, Teguh Triyono, Tomohiko Sato, Arwa Z Al-Riyami, Nasser Al-Kemyani, Marc Maegele, Vijay Kumawat, Parmatma Prasad Tripathi, Basanta Khatiwada, Marc Bienz, Alanna Howell, Philip J Crispin, Naomi Rahimi-Levene, Maha A Badawi, Salwa Hindawi, María Antonieta Núñez, Edgardo Saa, Riin Kullaste, Richard R Gammon, Marni Dargis, Samclide Mbikayi Mutindu, Alphonse Mosolo, Amalia Bravo Lindoro, Lise Estcourt, Nancy Dunbar","doi":"10.1111/vox.13760","DOIUrl":"10.1111/vox.13760","url":null,"abstract":"","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"80-88"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of amino acids and metabolites in the supernatant of stored concentrates blood from sickle cell trait (SCT) and reference (non-SCT) donors. 评估镰状细胞性状(SCT)和参照(非 SCT)捐献者储存的浓缩血液上清液中的氨基酸和代谢物。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-20 DOI: 10.1111/vox.13753
Mario A Izidoro, Daiane D A de Paula, Ingrid de Oliveira, Flávia R M Latini, Manoel J B C Girão, Afonso J P Cortez, Luiz Juliano

Background and objectives: Sickle cell trait (SCT) persons are significant donors, and discarding these blood units reduces their supplies, mainly in the third-world countries. This work focused on 12 metabolites associated with the red blood cell (RBC) storage lesion and 23 amino acids in the supernatants of packed RBC units from SCT and reference (non-SCT) donors stored in the same conditions.

Materials and methods: All samples of RBC concentrates were collected and separated from the storage of Colsan (Beneficient Association of Blood Collection), where they were routinely processed and separated as packed RBC units and stored in the refrigerator (2°-6°C). The supernatant samples of each packed RBC bag were separated by centrifugation at days 1, 7, 14, 21, 28 and 35 of storage and kept at -80°C till the metabolite analysis together.

Results: The quantitation of metabolites and amino acids examined in the supernatant of SCT and reference donors showed no statistical differences along the cold storage. Lactic acid and malic acid releases occur in three phases during RBC storage. Basic and acid amino acids and corresponding amides have low and stable values during the first 14 days of storage, followed by a steep increase.

Conclusion: Our metabolomic results give elements that seem not to contraindicate the transfusion of RBC with SCT, besides its more structural fragility.

背景和目的:镰状细胞性状(SCT)患者是重要的献血者,丢弃这些血液单位会减少血液供应,主要是在第三世界国家。这项工作的重点是研究与红细胞(RBC)储存病变有关的 12 种代谢物,以及在相同条件下储存的 SCT 和参照(非 SCT)捐献者的包装 RBC 单位上清液中的 23 种氨基酸:所有浓缩红细胞样本均从 Colsan(Beneficient Association of Blood Collection)的储存库中采集并分离出来,在该储存库中,浓缩红细胞被常规处理并分离为包装红细胞单位,储存在冰箱中(2°-6°C)。在储存的第 1、7、14、21、28 和 35 天,离心分离每个包装 RBC 袋的上清样品,并将其保存在 -80°C 温度下,直至代谢物分析:结果:SCT 和参考供体上清液中代谢物和氨基酸的定量检测结果显示,冷藏期间两者没有统计学差异。乳酸和苹果酸在红细胞贮藏期间分三个阶段释放。碱性氨基酸和酸性氨基酸以及相应的酰胺在贮藏的前 14 天中值较低且稳定,随后急剧上升:我们的代谢组学结果表明,除了结构更脆弱外,输注 SCT 红细胞似乎并无禁忌。
{"title":"Assessment of amino acids and metabolites in the supernatant of stored concentrates blood from sickle cell trait (SCT) and reference (non-SCT) donors.","authors":"Mario A Izidoro, Daiane D A de Paula, Ingrid de Oliveira, Flávia R M Latini, Manoel J B C Girão, Afonso J P Cortez, Luiz Juliano","doi":"10.1111/vox.13753","DOIUrl":"10.1111/vox.13753","url":null,"abstract":"<p><strong>Background and objectives: </strong>Sickle cell trait (SCT) persons are significant donors, and discarding these blood units reduces their supplies, mainly in the third-world countries. This work focused on 12 metabolites associated with the red blood cell (RBC) storage lesion and 23 amino acids in the supernatants of packed RBC units from SCT and reference (non-SCT) donors stored in the same conditions.</p><p><strong>Materials and methods: </strong>All samples of RBC concentrates were collected and separated from the storage of Colsan (Beneficient Association of Blood Collection), where they were routinely processed and separated as packed RBC units and stored in the refrigerator (2°-6°C). The supernatant samples of each packed RBC bag were separated by centrifugation at days 1, 7, 14, 21, 28 and 35 of storage and kept at -80°C till the metabolite analysis together.</p><p><strong>Results: </strong>The quantitation of metabolites and amino acids examined in the supernatant of SCT and reference donors showed no statistical differences along the cold storage. Lactic acid and malic acid releases occur in three phases during RBC storage. Basic and acid amino acids and corresponding amides have low and stable values during the first 14 days of storage, followed by a steep increase.</p><p><strong>Conclusion: </strong>Our metabolomic results give elements that seem not to contraindicate the transfusion of RBC with SCT, besides its more structural fragility.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"39-46"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal assessment of erythrogram parameters in response to granulocytapheresis frequency: A sex-based analysis. 红细胞图参数对粒细胞穿刺频率响应的纵向评估:基于性别的分析。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-01-01 DOI: 10.1111/vox.13788
Abdullah Alswied, Leonard N Chen, Kamille Aisha West-Mitchell

Background and objectives: Granulocyte transfusion supports patients with severe neutropenia. Maintaining a pool of eligible donors and optimizing donation frequency are essential for ensuring an adequate supply while safeguarding donor well-being. This study investigates the impact of donation frequency on erythrogram parameters, focusing on sex-specific differences.

Study design and methods: We conducted a retrospective analysis of 343 successive granulocyte collections from 65 apheresis donors over 11 years (2012-2023). Donors were categorized by sex, and erythrogram parameters were analysed in relation to donation frequency and intervals.

Results: Frequent donations within a short inter-donation interval (≥3 in 14 days) affected subsequent pre-donation haemoglobin levels. Each additional donation within 14 days led to a decrease of 0.81 g/dL in haemoglobin (p = 0.017). A significant interaction between sex and donations within 14 days (β = 0.76, p = 0.018) indicated that frequent donations had a more pronounced negative effect on haemoglobin levels in female donors. The proportion of donations meeting the pre-donation haemoglobin eligibility criteria declined with each successive donation within 14 days (100% at first, 85.8% at second, 25% at third). Female donors showed a significant haemoglobin reduction over three donations within 14 days (13.4-11.6 g/dL, p = 0.005) compared to males (14.4 -14 g/dL, p = 0.95).

Conclusion: Short inter-donation intervals have a more pronounced negative effect on pre-donation haemoglobin levels in female donors, underscoring the need for individualized donation guidelines to ensure donor safety.

背景和目的:粒细胞输注支持严重中性粒细胞减少症患者。维持一个合格的捐助者库和优化捐赠频率对于确保充足供应和保障捐助者福祉至关重要。本研究探讨了捐献频率对红细胞图参数的影响,重点是性别差异。研究设计和方法:我们对65例单采供者11年间(2012-2023年)连续收集的343例粒细胞进行了回顾性分析。献血者按性别分类,并分析红血图参数与捐献频率和间隔的关系。结果:短时间内频繁献血(14天内≥3次)会影响献血前血红蛋白水平。14天内每增加一次捐献,血红蛋白降低0.81 g/dL (p = 0.017)。性别与14天内捐献之间的显著相互作用(β = 0.76, p = 0.018)表明,频繁捐献对女性献血者血红蛋白水平的负面影响更为明显。14天内,每次连续献血,符合捐献前血红蛋白资格标准的献血比例都在下降(第一次100%,第二次85.8%,第三次25%)。与男性(14.4 -14 g/dL, p = 0.95)相比,女性献血者在14天内的三次献血者血红蛋白显著减少(13.4-11.6 g/dL, p = 0.005)。结论:较短的捐赠间隔对女性献血者捐献前血红蛋白水平有更明显的负面影响,强调有必要制定个性化的捐赠指南,以确保献血者的安全。
{"title":"Longitudinal assessment of erythrogram parameters in response to granulocytapheresis frequency: A sex-based analysis.","authors":"Abdullah Alswied, Leonard N Chen, Kamille Aisha West-Mitchell","doi":"10.1111/vox.13788","DOIUrl":"https://doi.org/10.1111/vox.13788","url":null,"abstract":"<p><strong>Background and objectives: </strong>Granulocyte transfusion supports patients with severe neutropenia. Maintaining a pool of eligible donors and optimizing donation frequency are essential for ensuring an adequate supply while safeguarding donor well-being. This study investigates the impact of donation frequency on erythrogram parameters, focusing on sex-specific differences.</p><p><strong>Study design and methods: </strong>We conducted a retrospective analysis of 343 successive granulocyte collections from 65 apheresis donors over 11 years (2012-2023). Donors were categorized by sex, and erythrogram parameters were analysed in relation to donation frequency and intervals.</p><p><strong>Results: </strong>Frequent donations within a short inter-donation interval (≥3 in 14 days) affected subsequent pre-donation haemoglobin levels. Each additional donation within 14 days led to a decrease of 0.81 g/dL in haemoglobin (p = 0.017). A significant interaction between sex and donations within 14 days (β = 0.76, p = 0.018) indicated that frequent donations had a more pronounced negative effect on haemoglobin levels in female donors. The proportion of donations meeting the pre-donation haemoglobin eligibility criteria declined with each successive donation within 14 days (100% at first, 85.8% at second, 25% at third). Female donors showed a significant haemoglobin reduction over three donations within 14 days (13.4-11.6 g/dL, p = 0.005) compared to males (14.4 -14 g/dL, p = 0.95).</p><p><strong>Conclusion: </strong>Short inter-donation intervals have a more pronounced negative effect on pre-donation haemoglobin levels in female donors, underscoring the need for individualized donation guidelines to ensure donor safety.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Forty-eight-hour cold-stored whole blood in paediatric cardiac surgery: Implications for haemostasis and blood donor exposures. 儿童心脏手术48小时冷藏全血:对止血和献血者暴露的影响。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2024-12-19 DOI: 10.1111/vox.13786
Amy L Kiskaddon, Jennifer Andrews, Cassandra D Josephson, Michael T Kuntz, Dominique Tran, Jennifer Jones, Vyas Kartha, Nhue L Do

Background and objectives: Cold-stored whole blood (CS-WB) in paediatric cardiac surgery is making a resurgence, given its identified benefits compared to conventional blood component therapy (CT).

Study design and methods: A single-centre retrospective study was conducted from January 2018 to October 2018 by including children <18 years of age undergoing cardiac surgery requiring cardiopulmonary bypass. ABO-compatible CS-WB from non-directed random donors was leukoreduced with platelet-sparing filters and compared with CT.

Results: Fifty-seven patients (30, 53% CS-WB; 27, 47% CT) were studied. Patient demographics were similar, although CT patients were cooled to a lower intra-operative temperature. Blood product requirements 24 h post operation were less in the CS-WB group (11.1 vs. 26.7 mL/kg, p = 0.048). Twelve (40%) patients in the CS-WB cohort had more than one donor exposure versus 25 (93%) in the CT group (p < 0.001). CT patients compared to CS-WB patients had a greater decrease in pre-operative versus 48-h post-operative haemoglobin, platelets and prothrombin time. Patients who received CT compared to CS-WB had a trend towards higher median (interquartile range [IQR]) chest-tube output (mL/kg/h) in the first 4 h post cardiac intensive care unit (ICU) admission (2.1 [0.8, 3] vs. 1.6 [0.8, 2.2], p = 0.197). There was no difference in antifibrinolytic use, length of stay, sepsis, acute kidney injury or wound infection. Survival to discharge was similar.

Conclusion: CS-WB in paediatric cardiac surgery may reduce donor exposure and improve haemostatic balance. Future multi-centre prospective studies are needed to validate these findings and identify patients who would benefit from CS-WB in paediatric cardiac surgery.

背景和目的:冷藏全血(CS-WB)在儿科心脏手术中的应用正在复苏,与传统血液成分治疗(CT)相比,它具有明显的优势。研究设计和方法:2018年1月至2018年10月进行了一项纳入儿童的单中心回顾性研究。结果:57例患者(30.53% CS-WB;27,47% CT)进行了研究。尽管CT患者术中温度较低,但患者人口统计学相似。CS-WB组术后24 h需血量较低(11.1 mL/kg vs. 26.7 mL/kg, p = 0.048)。CS-WB组中有12例(40%)患者有不止一个供体暴露,而CT组中有25例(93%)患者有不止一个供体暴露(p结论:CS-WB在儿科心脏手术中可以减少供体暴露并改善止血平衡。未来的多中心前瞻性研究需要验证这些发现,并确定在儿科心脏手术中受益于CS-WB的患者。
{"title":"Forty-eight-hour cold-stored whole blood in paediatric cardiac surgery: Implications for haemostasis and blood donor exposures.","authors":"Amy L Kiskaddon, Jennifer Andrews, Cassandra D Josephson, Michael T Kuntz, Dominique Tran, Jennifer Jones, Vyas Kartha, Nhue L Do","doi":"10.1111/vox.13786","DOIUrl":"https://doi.org/10.1111/vox.13786","url":null,"abstract":"<p><strong>Background and objectives: </strong>Cold-stored whole blood (CS-WB) in paediatric cardiac surgery is making a resurgence, given its identified benefits compared to conventional blood component therapy (CT).</p><p><strong>Study design and methods: </strong>A single-centre retrospective study was conducted from January 2018 to October 2018 by including children <18 years of age undergoing cardiac surgery requiring cardiopulmonary bypass. ABO-compatible CS-WB from non-directed random donors was leukoreduced with platelet-sparing filters and compared with CT.</p><p><strong>Results: </strong>Fifty-seven patients (30, 53% CS-WB; 27, 47% CT) were studied. Patient demographics were similar, although CT patients were cooled to a lower intra-operative temperature. Blood product requirements 24 h post operation were less in the CS-WB group (11.1 vs. 26.7 mL/kg, p = 0.048). Twelve (40%) patients in the CS-WB cohort had more than one donor exposure versus 25 (93%) in the CT group (p < 0.001). CT patients compared to CS-WB patients had a greater decrease in pre-operative versus 48-h post-operative haemoglobin, platelets and prothrombin time. Patients who received CT compared to CS-WB had a trend towards higher median (interquartile range [IQR]) chest-tube output (mL/kg/h) in the first 4 h post cardiac intensive care unit (ICU) admission (2.1 [0.8, 3] vs. 1.6 [0.8, 2.2], p = 0.197). There was no difference in antifibrinolytic use, length of stay, sepsis, acute kidney injury or wound infection. Survival to discharge was similar.</p><p><strong>Conclusion: </strong>CS-WB in paediatric cardiac surgery may reduce donor exposure and improve haemostatic balance. Future multi-centre prospective studies are needed to validate these findings and identify patients who would benefit from CS-WB in paediatric cardiac surgery.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oropouche virus in Brazil: Assessing the risks and challenges for transfusion medicine. 巴西的Oropouche病毒:评估输血医学的风险和挑战。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2024-12-19 DOI: 10.1111/vox.13784
Lucca Rocha Policastro, Debora Glenda Lima de La-Roque, Rodrigo Tocantins Calado, Dimas Tadeu Covas, Luiz Carlos Alcantara, Marta Giovanetti, Simone Kashima
{"title":"Oropouche virus in Brazil: Assessing the risks and challenges for transfusion medicine.","authors":"Lucca Rocha Policastro, Debora Glenda Lima de La-Roque, Rodrigo Tocantins Calado, Dimas Tadeu Covas, Luiz Carlos Alcantara, Marta Giovanetti, Simone Kashima","doi":"10.1111/vox.13784","DOIUrl":"https://doi.org/10.1111/vox.13784","url":null,"abstract":"","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viability of Plasmodium falciparum parasites in human plasma under different storage conditions. 不同贮存条件下恶性疟原虫在人血浆中的生存能力。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2024-12-11 DOI: 10.1111/vox.13781
Anna Lavrentieva, Miranda S Oakley, Clifford T H Hayashi, Victoria F Majam, Anne F Eder, Carlos H Villa, Sanjai Kumar

Background and objectives: Malaria risk deferral policies are important for mitigating the risk of transfusion-transmitted malaria and apply to all transfusable components, including plasma. While donors of plasma components are deferred for malaria risk in the United States, the viability of intraerythrocytic Plasmodium falciparum parasites present in human plasma components stored under different temperatures and durations has not been previously reported.

Materials and methods: We spiked human plasma with a low level of ring-stage P. falciparum-infected red blood cells and then determined their viability in cultures after storage at room temperature (22°C), refrigeration (4°C) and frozen conditions at -20 and -80°C.

Results: P. falciparum parasites spiked in human plasma remained viable after storage at 22°C for a maximum of 7 days. When stored at 4°C, parasites were viable after 1 and 3 days of storage and only for 1 day after storage at -20°C. Storage at -80°C had a cryopreserving effect and parasites remained viable for up to 176 days, the longest period tested.

Conclusion: P. falciparum parasites can survive for short durations in human plasma when stored at room temperature, or in refrigerated or frozen conditions at -20°C. However, when stored at -80°C, viable parasites were detected for up to 176 days, the maximum duration for which viability was assessed. In summary, Plasmodium parasites can survive in human plasma under different storage conditions and pose a risk of transfusion-transmitted infection.

背景和目标:疟疾风险延迟政策对于减轻输血传播疟疾的风险非常重要,并适用于包括血浆在内的所有可输注成分。虽然在美国,血浆组分的供体因疟疾风险而被推迟,但在不同温度和持续时间下储存的人血浆组分中存在的红细胞内恶性疟原虫寄生虫的生存能力以前没有报道。材料和方法:我们在人血浆中加入低水平的环期恶性疟原虫感染的红细胞,然后在室温(22°C)、冷藏(4°C)和-20和-80°C冷冻条件下测定其在培养物中的生存能力。结果:人血浆中的恶性疟原虫在22℃下保存最多7天后仍能存活。在4°C条件下,寄生物在1天和3天后都有活力,在-20°C条件下寄生物在1天后才有活力。在-80°C的低温保存条件下,寄生虫可以存活176天,这是实验中最长的时间。结论:恶性疟原虫在室温、-20℃冷藏或冷冻条件下可在人血浆中存活较短时间。然而,当储存在-80°C时,可检测到活寄生虫长达176天,这是评估活力的最长持续时间。总之,疟原虫可以在不同的储存条件下在人血浆中存活,并具有输血传播感染的风险。
{"title":"Viability of Plasmodium falciparum parasites in human plasma under different storage conditions.","authors":"Anna Lavrentieva, Miranda S Oakley, Clifford T H Hayashi, Victoria F Majam, Anne F Eder, Carlos H Villa, Sanjai Kumar","doi":"10.1111/vox.13781","DOIUrl":"https://doi.org/10.1111/vox.13781","url":null,"abstract":"<p><strong>Background and objectives: </strong>Malaria risk deferral policies are important for mitigating the risk of transfusion-transmitted malaria and apply to all transfusable components, including plasma. While donors of plasma components are deferred for malaria risk in the United States, the viability of intraerythrocytic Plasmodium falciparum parasites present in human plasma components stored under different temperatures and durations has not been previously reported.</p><p><strong>Materials and methods: </strong>We spiked human plasma with a low level of ring-stage P. falciparum-infected red blood cells and then determined their viability in cultures after storage at room temperature (22°C), refrigeration (4°C) and frozen conditions at -20 and -80°C.</p><p><strong>Results: </strong>P. falciparum parasites spiked in human plasma remained viable after storage at 22°C for a maximum of 7 days. When stored at 4°C, parasites were viable after 1 and 3 days of storage and only for 1 day after storage at -20°C. Storage at -80°C had a cryopreserving effect and parasites remained viable for up to 176 days, the longest period tested.</p><p><strong>Conclusion: </strong>P. falciparum parasites can survive for short durations in human plasma when stored at room temperature, or in refrigerated or frozen conditions at -20°C. However, when stored at -80°C, viable parasites were detected for up to 176 days, the maximum duration for which viability was assessed. In summary, Plasmodium parasites can survive in human plasma under different storage conditions and pose a risk of transfusion-transmitted infection.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Restless legs syndrome among blood donors: A systemic review and meta-analysis. 献血者中的不宁腿综合征:一项系统回顾和荟萃分析。
IF 1.8 4区 医学 Q3 HEMATOLOGY Pub Date : 2024-12-10 DOI: 10.1111/vox.13780
Alain M Ngoma, Paulin B Mutombo, Mahmoud Mosli, Magot D Omokoko, Kenneth E Nollet, Hitoshi Ohto

Background and objectives: Restless legs syndrome (RLS), with adverse health outcomes, has been linked to blood donation, but evidence published thus far has not been rigorously analysed. This systematic review aggregates existing evidence on RLS among blood donors and identifies associated factors worthy of further investigation.

Materials and methods: MEDLINE and EMBASE were searched for articles published through 16 December 2023. Eleven studies from eight countries were selected from 142 publications. The pooled prevalence of RLS was calculated using a random-effects model, with heterogeneity assessed by the Cochran Q and I2 statistics. Meta-regression and sensitivity analyses explored sources of heterogeneity and the robustness of findings.

Results: Eleven studies, involving 20,255 blood donors, were included. The pooled prevalence of RLS among blood donors was 10.30% (95% confidence interval [CI]: 5.54%-16.30%), which was significantly higher than in the general adult population (3.0%, 95% CI: 1.4%-3.8%). Meta-regression identified the year of study and geographical region as significant sources of heterogeneity. From the five studies that used logistic regression analyses, female sex and older age stand out as associated factors. No publication bias was detected, and sensitivity analysis confirmed the robustness of results.

Conclusion: Our findings suggest a high burden of RLS among blood donors, underscoring the need for further research with standardized criteria, appropriate design and analytical methodologies to better understand the impact of RLS on individual donors and the global blood supply.

背景和目的:不宁腿综合征(RLS)具有不良的健康后果,与献血有关,但迄今为止发表的证据尚未得到严格分析。本系统综述收集了献血者中RLS的现有证据,并确定了值得进一步调查的相关因素。材料和方法:检索截至2023年12月16日发表的文章。从142份出版物中选择了来自8个国家的11项研究。使用随机效应模型计算RLS的总患病率,并通过Cochran Q和I2统计来评估异质性。meta回归和敏感性分析探讨了异质性的来源和研究结果的稳健性。结果:纳入了11项研究,涉及20,255名献血者。献血者中RLS的总患病率为10.30%(95%可信区间[CI]: 5.54% ~ 16.30%),显著高于普通成人(3.0%,95% CI: 1.4% ~ 3.8%)。元回归确定研究年份和地理区域是异质性的重要来源。从使用逻辑回归分析的五项研究中,女性性别和年龄较大是突出的相关因素。未发现发表偏倚,敏感性分析证实了结果的稳健性。结论:我们的研究结果表明,RLS在献血者中负担很高,需要进一步研究标准化标准,适当的设计和分析方法,以更好地了解RLS对个体献血者和全球血液供应的影响。
{"title":"Restless legs syndrome among blood donors: A systemic review and meta-analysis.","authors":"Alain M Ngoma, Paulin B Mutombo, Mahmoud Mosli, Magot D Omokoko, Kenneth E Nollet, Hitoshi Ohto","doi":"10.1111/vox.13780","DOIUrl":"https://doi.org/10.1111/vox.13780","url":null,"abstract":"<p><strong>Background and objectives: </strong>Restless legs syndrome (RLS), with adverse health outcomes, has been linked to blood donation, but evidence published thus far has not been rigorously analysed. This systematic review aggregates existing evidence on RLS among blood donors and identifies associated factors worthy of further investigation.</p><p><strong>Materials and methods: </strong>MEDLINE and EMBASE were searched for articles published through 16 December 2023. Eleven studies from eight countries were selected from 142 publications. The pooled prevalence of RLS was calculated using a random-effects model, with heterogeneity assessed by the Cochran Q and I<sup>2</sup> statistics. Meta-regression and sensitivity analyses explored sources of heterogeneity and the robustness of findings.</p><p><strong>Results: </strong>Eleven studies, involving 20,255 blood donors, were included. The pooled prevalence of RLS among blood donors was 10.30% (95% confidence interval [CI]: 5.54%-16.30%), which was significantly higher than in the general adult population (3.0%, 95% CI: 1.4%-3.8%). Meta-regression identified the year of study and geographical region as significant sources of heterogeneity. From the five studies that used logistic regression analyses, female sex and older age stand out as associated factors. No publication bias was detected, and sensitivity analysis confirmed the robustness of results.</p><p><strong>Conclusion: </strong>Our findings suggest a high burden of RLS among blood donors, underscoring the need for further research with standardized criteria, appropriate design and analytical methodologies to better understand the impact of RLS on individual donors and the global blood supply.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vox Sanguinis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1